Healthcare Stock Screening Records
0 positive ratio indicators
1210 total screened
Healthcare Stock Records (1210)
Showing up to 500 records. Market-cap amounts remain in each listing's native currency and are not comparable across currencies. Use the screener or stock index for all 1210 records.
| Ticker | Company | Industry | Exchange | Market Cap | Debt Ratio | Status |
|---|---|---|---|---|---|---|
| 207940 | Samsung Bio | Biotechnology | KSC | 56.7T native | 8.4% | MORE DATA NEEDED* |
| 068270 | Celltrion | Biotechnology | KSC | 41.0T native | 16.7% | MORE DATA NEEDED* |
| KLBF | Kalbe Farma | Drug Manufacturers - General | JKT | 34.8T native | 1.0% | POTENTIALLY NON-COMPLIANT* |
| 4519 | Chugai Pharma | Drug Manufacturers - General | TSE | 9.9T native | N/A | POTENTIALLY NON-COMPLIANT* |
| 4502 | Takeda | Drug Manufacturers - Specialty & Generic | TSE | 9.3T native | 31.5% | POTENTIALLY NON-COMPLIANT* |
| 7741 | 7741 | Medical Instruments & Supplies | TSE | 8.3T native | 3.2% | POTENTIALLY NON-COMPLIANT* |
| 4568 | Daiichi Sankyo | Drug Manufacturers - General | TSE | 4.8T native | 7.5% | MORE DATA NEEDED* |
| SUNPHARMA | Sun Pharma | Drug Manufacturers - Specialty & Generic | NSE | 4.2T native | 4.3% | POTENTIALLY NON-COMPLIANT* |
| 4503 | Astellas Pharma | Drug Manufacturers - General | TSE | 4.0T native | 15.9% | MORE DATA NEEDED* |
| DIVISLAB | Divis Labs | Drug Manufacturers - Specialty & Generic | NSE | 2.5T native | 0.0% | MORE DATA NEEDED* |
| APOLLOHOSP | Apollo Hospitals | Medical Care Facilities | NSE | 1.2T native | 38.3% | POTENTIALLY NON-COMPLIANT* |
| CIPLA | Cipla | Drug Manufacturers - Specialty & Generic | NSE | 1.1T native | 1.4% | MORE DATA NEEDED* |
| LLY | ELI LILLY & Co | Drug Manufacturers - General | NYSE | 1.0T native | 37.8% | POTENTIALLY NON-COMPLIANT* |
| DRREDDY | Dr Reddy's | Drug Manufacturers - Specialty & Generic | NSE | 997.1B native | 13.3% | MORE DATA NEEDED* |
| JNJ | JOHNSON & JOHNSON | Drug Manufacturers - General | NYSE | 644.1B native | 24.1% | MORE DATA NEEDED* |
| ABBV | AbbVie Inc. | Drug Manufacturers - General | NYSE | 463.9B native | 50.4% | POTENTIALLY NON-COMPLIANT* |
| MRK | Merck & Co., Inc. | Drug Manufacturers - General | NYSE | 357.5B native | 36.0% | POTENTIALLY NON-COMPLIANT* |
| UNH | UNITEDHEALTH GROUP INC | Healthcare Plans | NYSE | 336.8B native | 25.3% | MORE DATA NEEDED* |
| NVS | NOVARTIS AG | Drug Manufacturers - General | NYSE | 263.6B native | 31.9% | POTENTIALLY NON-COMPLIANT* |
| ROG | Roche | Drug Manufacturers - General | SWX | 256.4B native | 33.0% | POTENTIALLY NON-COMPLIANT* |
| AZN | ASTRAZENECA PLC | Drug Manufacturers - General | NYSE | 252.6B native | 25.6% | MORE DATA NEEDED* |
| TMO | THERMO FISHER SCIENTIFIC INC. | Diagnostics & Research | NYSE | 239.8B native | 35.7% | POTENTIALLY NON-COMPLIANT* |
| NOVN | Novartis | Drug Manufacturers - General | SWX | 223.8B native | 31.9% | POTENTIALLY NON-COMPLIANT* |
| 2269 | WuXi Bio | Biotechnology | HKSE | 221.7B native | 4.9% | MORE DATA NEEDED* |
| AMGN | AMGEN INC | Drug Manufacturers - General | NASDAQ | 203.5B native | 60.3% | POTENTIALLY NON-COMPLIANT* |
| AMGN-nyse-8219 | Amgen | Drug Manufacturers - General | NYSE | 188.0B native | 60.3% | POTENTIALLY NON-COMPLIANT* |
| AZN-lse-151 | AstraZeneca | Drug Manufacturers - General | LSE | 184.4B native | 25.6% | MORE DATA NEEDED* |
| NVO | NOVO NORDISK A S | Drug Manufacturers - General | NYSE | 184.3B native | 24.1% | MORE DATA NEEDED* |
| GILD | GILEAD SCIENCES, INC. | Drug Manufacturers - General | NASDAQ | 183.1B native | 42.2% | POTENTIALLY NON-COMPLIANT* |
| ABT | ABBOTT LABORATORIES | Medical Devices | NYSE | 177.1B native | 16.0% | MORE DATA NEEDED* |
| GILD-nyse-8278 | Gilead Sciences | Drug Manufacturers - General | NYSE | 166.6B native | 42.2% | POTENTIALLY NON-COMPLIANT* |
| ISRG | Intuitive Surgical | Medical Instruments & Supplies | NYSE | 160.8B native | N/A | MORE DATA NEEDED* |
| PFE | PFIZER INC | Drug Manufacturers - General | NYSE | 156.5B native | 30.7% | POTENTIALLY NON-COMPLIANT* |
| DHR | DANAHER CORP /DE/ | Diagnostics & Research | NYSE | 146.5B native | 23.6% | MORE DATA NEEDED* |
| ISRG-nasdaq-88 | INTUITIVE SURGICAL INC | Medical Instruments & Supplies | NASDAQ | 137.0B native | N/A | MORE DATA NEEDED* |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Biotechnology | NASDAQ | 130.1B native | 7.9% | MORE DATA NEEDED* |
| BMY | BRISTOL MYERS SQUIBB CO | Drug Manufacturers - General | NYSE | 129.9B native | 52.4% | POTENTIALLY NON-COMPLIANT* |
| MDT | Medtronic plc | Medical Devices | NYSE | 118.4B native | 30.1% | POTENTIALLY NON-COMPLIANT* |
| CVS | CVS HEALTH Corp | Healthcare Plans | NYSE | 117.3B native | 31.5% | POTENTIALLY NON-COMPLIANT* |
| VRTX-nyse-8360 | Vertex Pharmaceuticals | Biotechnology | NYSE | 110.0B native | 7.9% | MORE DATA NEEDED* |
| SYK | STRYKER CORP | Medical Devices | NYSE | 109.2B native | 33.1% | POTENTIALLY NON-COMPLIANT* |
| 1093 | CSPC Pharma | Drug Manufacturers - General | HKSE | 103.6B native | 1.4% | MORE DATA NEEDED* |
| MCK | MCKESSON CORP | Medical Distribution | NYSE | 103.4B native | 10.5% | POTENTIALLY NON-COMPLIANT* |
| SNY | Sanofi | Drug Manufacturers - General | NASDAQ | 102.1B native | 16.0% | MORE DATA NEEDED* |
| GSK | GSK plc | Drug Manufacturers - General | NYSE | 100.7B native | 29.0% | MORE DATA NEEDED* |
| 1177 | Sino Biopharm | Biotechnology | HKSE | 96.4B native | 21.1% | POTENTIALLY NON-COMPLIANT* |
| HCA | HCA Healthcare, Inc. | Medical Care Facilities | NYSE | 93.2B native | 80.2% | POTENTIALLY NON-COMPLIANT* |
| ELV | Elevance Health, Inc. | Healthcare Plans | NYSE | 89.8B native | 26.4% | MORE DATA NEEDED* |
| CSL | CSL Limited | Biotechnology | ASX | 87.6B native | 32.4% | POTENTIALLY NON-COMPLIANT* |
| SAN-par-191 | Sanofi | Drug Manufacturers - General | PAR | 85.0B native | 16.0% | MORE DATA NEEDED* |
| 4013 | NASEEJ | Medical Care Facilities | SAU | 80.0B native | 40.1% | POTENTIALLY NON-COMPLIANT* |
| REGN | REGENERON PHARMACEUTICALS, INC. | Biotechnology | NASDAQ | 79.7B native | 6.7% | MORE DATA NEEDED* |
| REGN-nyse-8335 | Regeneron Pharmaceuticals | Biotechnology | NYSE | 78.0B native | 6.7% | MORE DATA NEEDED* |
| CI | Cigna Group | Healthcare Plans | NYSE | 74.1B native | 19.9% | MORE DATA NEEDED* |
| GSK-lse-154 | GSK plc | Drug Manufacturers - General | LSE | 69.5B native | 29.0% | MORE DATA NEEDED* |
| 5225 | IHH Healthcare | Medical Care Facilities | KLS | 69.5B native | 27.0% | MORE DATA NEEDED* |
| EL | EssilorLuxottica | Medical Instruments & Supplies | PAR | 67.1B native | 22.5% | MORE DATA NEEDED* |
| BSX | BOSTON SCIENTIFIC CORP | Medical Devices | NYSE | 63.6B native | 26.2% | MORE DATA NEEDED* |
| ARGX | ARGENX SE | Biotechnology | NASDAQ | 61.9B native | 0.5% | POTENTIALLY NON-COMPLIANT* |
| TAK | TAKEDA PHARMACEUTICAL CO LTD | Drug Manufacturers - Specialty & Generic | NYSE | 60.8B native | 31.5% | POTENTIALLY NON-COMPLIANT* |
| COR | Cencora, Inc. | Medical Distribution | NYSE | 59.0B native | 10.0% | POTENTIALLY NON-COMPLIANT* |
| MRK-xetra-182 | Merck KGaA | Drug Manufacturers - Specialty & Generic | XETRA | 59.0B native | 23.2% | MORE DATA NEEDED* |
| MRNA | Moderna, Inc. | Biotechnology | NASDAQ | 58.1B native | 10.6% | POTENTIALLY NON-COMPLIANT* |
| NTRA | Natera, Inc. | Diagnostics & Research | NASDAQ | 52.8B native | 8.9% | POTENTIALLY NON-COMPLIANT* |
| CAH | CARDINAL HEALTH INC | Medical Distribution | NYSE | 52.6B native | 15.5% | POTENTIALLY NON-COMPLIANT* |
| EW | Edwards Lifesciences Corp | Medical Devices | NYSE | 50.9B native | 5.2% | POTENTIALLY NON-COMPLIANT* |
| BDX | BECTON DICKINSON & CO | Medical Instruments & Supplies | NYSE | 49.5B native | 34.7% | POTENTIALLY NON-COMPLIANT* |
| A-amex-8449 | A | Diagnostics & Research | AMEX | 48.1B native | 26.4% | MORE DATA NEEDED* |
| HUM | HUMANA INC | Healthcare Plans | NYSE | 46.4B native | 25.3% | POTENTIALLY NON-COMPLIANT* |
| 0241 | Alibaba Health | Pharmaceutical Retailers | HKSE | 46.3B native | 0.3% | POTENTIALLY NON-COMPLIANT* |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Drug Manufacturers - Specialty & Generic | NYSE | 45.7B native | 42.0% | POTENTIALLY NON-COMPLIANT* |
| IDXX | Idexx Laboratories | Diagnostics & Research | NYSE | 44.6B native | 29.1% | MORE DATA NEEDED* |
| IQV | IQVIA HOLDINGS INC. | Diagnostics & Research | NYSE | 44.3B native | 53.3% | POTENTIALLY NON-COMPLIANT* |
| A | AGILENT TECHNOLOGIES, INC. | Diagnostics & Research | NYSE | 44.1B native | 26.4% | MORE DATA NEEDED* |
| SHL | Siemens Healthineers | Medical Devices | XETRA | 43.8B native | N/A | MORE DATA NEEDED* |
| MDLN | Medline Inc. | Medical Instruments & Supplies | NASDAQ | 43.2B native | 32.8% | POTENTIALLY NON-COMPLIANT* |
| VEEV | VEEVA SYSTEMS INC | Health Information Services | NYSE | 42.7B native | 1.1% | POTENTIALLY NON-COMPLIANT* |
| WAT | WATERS CORP /DE/ | Diagnostics & Research | NYSE | 42.2B native | 29.4% | MORE DATA NEEDED* |
| HLN | Haleon plc | Drug Manufacturers - Specialty & Generic | NYSE | 41.0B native | 26.3% | MORE DATA NEEDED* |
| RVMD | Revolution Medicines, Inc. | Biotechnology | NASDAQ | 40.9B native | 6.7% | POTENTIALLY NON-COMPLIANT* |
| IDXX-nasdaq-147 | IDEXX LABORATORIES INC /DE | Diagnostics & Research | NASDAQ | 40.5B native | 29.1% | MORE DATA NEEDED* |
| ONC | BeOne Medicines Ltd. | Biotechnology | NASDAQ | 40.0B native | 13.3% | POTENTIALLY NON-COMPLIANT* |
| LONN | Lonza | Diagnostics & Research | SWX | 39.4B native | 25.4% | MORE DATA NEEDED* |
| ILMN | ILLUMINA, INC. | Diagnostics & Research | NASDAQ | 34.6B native | 38.4% | POTENTIALLY NON-COMPLIANT* |
| RPRX | Royalty Pharma plc | Biotechnology | NASDAQ | 34.1B native | 45.6% | POTENTIALLY NON-COMPLIANT* |
| DXCM | DEXCOM INC | Medical Devices | NASDAQ | 33.0B native | 21.9% | POTENTIALLY NON-COMPLIANT* |
| RMD | RESMED INC | Medical Instruments & Supplies | NYSE | 33.0B native | 9.2% | MORE DATA NEEDED* |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Biotechnology | NASDAQ | 32.9B native | 25.7% | POTENTIALLY NON-COMPLIANT* |
| CNC | CENTENE CORP | Healthcare Plans | NYSE | 32.2B native | 23.7% | POTENTIALLY NON-COMPLIANT* |
| BIIB | BIOGEN INC. | Drug Manufacturers - General | NASDAQ | 31.9B native | 22.3% | MORE DATA NEEDED* |
| BIIB-nyse-8231 | Biogen | Drug Manufacturers - General | NYSE | 31.9B native | 22.3% | MORE DATA NEEDED* |
| GEHC | GE HealthCare | Medical Devices | NYSE | 31.6B native | 28.4% | MORE DATA NEEDED* |
| ALC | ALCON INC | Medical Instruments & Supplies | NYSE | 31.5B native | N/A | MORE DATA NEEDED* |
| ZTS | Zoetis Inc. | Drug Manufacturers - Specialty & Generic | NYSE | 30.2B native | 59.7% | POTENTIALLY NON-COMPLIANT* |
| ZTS-nasdaq-146 | ZTS | Drug Manufacturers - Specialty & Generic | NASDAQ | 30.2B native | 59.7% | POTENTIALLY NON-COMPLIANT* |
| GEHC-nasdaq-738 | GE HealthCare Technologies Inc. | Medical Devices | NASDAQ | 29.1B native | 28.4% | MORE DATA NEEDED* |
| ROIV | Roivant Sciences Ltd. | Biotechnology | NASDAQ | 28.7B native | 1.9% | POTENTIALLY NON-COMPLIANT* |
| MTD | METTLER TOLEDO INTERNATIONAL INC/ | Diagnostics & Research | NYSE | 28.3B native | 58.0% | POTENTIALLY NON-COMPLIANT* |
| DGX | QUEST DIAGNOSTICS INC | Diagnostics & Research | NYSE | 27.2B native | 40.6% | POTENTIALLY NON-COMPLIANT* |
| INSM | INSMED Inc | Biotechnology | NASDAQ | 27.1B native | 25.3% | POTENTIALLY NON-COMPLIANT* |
| LH | LABCORP HOLDINGS INC. | Diagnostics & Research | NYSE | 26.0B native | 35.5% | POTENTIALLY NON-COMPLIANT* |
| WST | WEST PHARMACEUTICAL SERVICES INC | Medical Instruments & Supplies | NYSE | 25.5B native | 7.5% | POTENTIALLY NON-COMPLIANT* |
| INCY | INCYTE CORP | Biotechnology | NASDAQ | 25.4B native | 0.6% | POTENTIALLY NON-COMPLIANT* |
| FRE | Fresenius | Medical Care Facilities | XETRA | 24.6B native | 28.8% | MORE DATA NEEDED* |
| DXCM-nyse-8255 | Dexcom | Medical Devices | NYSE | 24.3B native | 21.9% | POTENTIALLY NON-COMPLIANT* |
| PHG | KONINKLIJKE PHILIPS NV | Medical Devices | NYSE | 24.1B native | 29.0% | MORE DATA NEEDED* |
| BNTX | BioNTech SE | Biotechnology | NASDAQ | 24.1B native | 1.2% | POTENTIALLY NON-COMPLIANT* |
| GH | Guardant Health, Inc. | Diagnostics & Research | NASDAQ | 24.1B native | 84.9% | POTENTIALLY NON-COMPLIANT* |
| GMAB | GENMAB A/S | Biotechnology | NASDAQ | 21.4B native | 42.2% | POTENTIALLY NON-COMPLIANT* |
| UTHR | UNITED THERAPEUTICS Corp | Drug Manufacturers - Specialty & Generic | NASDAQ | 21.2B native | N/A | POTENTIALLY NON-COMPLIANT* |
| THC | TENET HEALTHCARE CORP | Medical Care Facilities | NYSE | 21.1B native | 44.4% | POTENTIALLY NON-COMPLIANT* |
| PHIA | Philips | Medical Devices | AMS | 21.0B native | 29.0% | MORE DATA NEEDED* |
| EXAS | EXACT SCIENCES CORP | Diagnostics & Research | NASDAQ | 20.0B native | 43.0% | POTENTIALLY NON-COMPLIANT* |
| STE | STERIS plc | Medical Devices | NYSE | 20.0B native | 19.4% | MORE DATA NEEDED* |
| MRNA-nyse-8307 | Moderna | Biotechnology | NYSE | 19.7B native | 10.6% | POTENTIALLY NON-COMPLIANT* |
| VTRS | Viatris Inc | Drug Manufacturers - Specialty & Generic | NASDAQ | 19.5B native | 39.5% | POTENTIALLY NON-COMPLIANT* |
| ZBH | ZIMMER BIOMET HOLDINGS, INC. | Medical Devices | NYSE | 18.2B native | 32.6% | POTENTIALLY NON-COMPLIANT* |
| INCY-nyse-8286 | Incyte | Biotechnology | NYSE | 18.0B native | 0.6% | POTENTIALLY NON-COMPLIANT* |
| SRT3 | Sartorius | Medical Instruments & Supplies | XETRA | 17.5B native | 44.1% | POTENTIALLY NON-COMPLIANT* |
| MEDP | Medpace Holdings, Inc. | Diagnostics & Research | NASDAQ | 17.1B native | 5.8% | POTENTIALLY NON-COMPLIANT* |
| HOLX | HOLOGIC INC | Medical Instruments & Supplies | NASDAQ | 16.9B native | 29.1% | MORE DATA NEEDED* |
| HOLX-nyse-8281 | Hologic | Medical Instruments & Supplies | NYSE | 16.9B native | 29.1% | MORE DATA NEEDED* |
| RVTY | REVVITY, INC. | Diagnostics & Research | NYSE | 16.0B native | 27.9% | MORE DATA NEEDED* |
| JAZZ | Jazz Pharmaceuticals plc | Biotechnology | NASDAQ | 15.6B native | 46.5% | POTENTIALLY NON-COMPLIANT* |
| ASND | Ascendis Pharma A/S | Biotechnology | NASDAQ | 15.6B native | 66.9% | POTENTIALLY NON-COMPLIANT* |
| SOLV | Solventum Corp | Medical Instruments & Supplies | NYSE | 15.1B native | 35.2% | POTENTIALLY NON-COMPLIANT* |
| VTRS-nyse-8361 | Viatris | Drug Manufacturers - Specialty & Generic | NYSE | 15.0B native | 39.5% | POTENTIALLY NON-COMPLIANT* |
| NBIX | NEUROCRINE BIOSCIENCES INC | Drug Manufacturers - Specialty & Generic | NASDAQ | 14.9B native | 9.0% | POTENTIALLY NON-COMPLIANT* |
| PODD | Insulet Corporation | Medical Devices | NYSE | 14.7B native | 29.8% | POTENTIALLY NON-COMPLIANT* |
| EXEL | EXELIXIS, INC. | Biotechnology | NASDAQ | 14.5B native | 6.1% | POTENTIALLY NON-COMPLIANT* |
| SMMT | Summit Therapeutics Inc. | Biotechnology | NASDAQ | 14.2B native | 2.8% | POTENTIALLY NON-COMPLIANT* |
| TEM | Tempus AI, Inc. | Health Information Services | NASDAQ | 14.0B native | 58.3% | POTENTIALLY NON-COMPLIANT* |
| COO | Cooper Companies (The) | Medical Instruments & Supplies | NYSE | 13.6B native | 20.2% | MORE DATA NEEDED* |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Diagnostics & Research | NYSE | 13.4B native | 36.0% | POTENTIALLY NON-COMPLIANT* |
| ERF | Eurofins | Diagnostics & Research | PAR | 13.2B native | 40.3% | POTENTIALLY NON-COMPLIANT* |
| BBIO | BridgeBio Pharma, Inc. | Biotechnology | NASDAQ | 13.0B native | 199.0% | POTENTIALLY NON-COMPLIANT* |
| HALO | HALOZYME THERAPEUTICS, INC. | Biotechnology | NASDAQ | 12.8B native | 84.8% | POTENTIALLY NON-COMPLIANT* |
| RGC | Regencell Bioscience Holdings Ltd | Drug Manufacturers - Specialty & Generic | NASDAQ | 12.7B native | 1.0% | POTENTIALLY NON-COMPLIANT* |
| ICLR | ICON PLC | Diagnostics & Research | NASDAQ | 12.7B native | 21.9% | MORE DATA NEEDED* |
| PEN | Penumbra Inc | Medical Devices | NYSE | 12.5B native | 12.0% | MORE DATA NEEDED* |
| 4002 | Mouwasat Medical | Medical Care Facilities | SAU | 12.4B native | 16.5% | MORE DATA NEEDED* |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Biotechnology | NASDAQ | 12.4B native | 8.0% | MORE DATA NEEDED* |
| CORT | CORCEPT THERAPEUTICS INC | Biotechnology | NASDAQ | 12.3B native | 0.7% | POTENTIALLY NON-COMPLIANT* |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Biotechnology | NASDAQ | 12.3B native | 27.6% | POTENTIALLY NON-COMPLIANT* |
| EHC | Encompass Health Corp | Medical Care Facilities | NYSE | 12.0B native | 38.3% | POTENTIALLY NON-COMPLIANT* |
| ALGN | Align Technology | Medical Instruments & Supplies | NYSE | 11.9B native | 1.8% | POTENTIALLY NON-COMPLIANT* |
| FMS | Fresenius Medical Care AG | Medical Care Facilities | NYSE | 11.8B native | 34.8% | POTENTIALLY NON-COMPLIANT* |
| BAX | BAXTER INTERNATIONAL INC | Medical Instruments & Supplies | NYSE | 11.8B native | 48.8% | POTENTIALLY NON-COMPLIANT* |
| DVA | DAVITA INC. | Medical Care Facilities | NYSE | 11.7B native | 73.7% | POTENTIALLY NON-COMPLIANT* |
| SNN | SMITH & NEPHEW PLC | Medical Devices | NYSE | 11.5B native | 31.8% | POTENTIALLY NON-COMPLIANT* |
| TECH | BIO-TECHNE Corp | Biotechnology | NASDAQ | 11.3B native | 11.2% | MORE DATA NEEDED* |
| RNAM | Avidity Biosciences, Inc. | Biotechnology | NASDAQ | 11.2B native | 2.5% | POTENTIALLY NON-COMPLIANT* |
| BTSG | BrightSpring Health Services, Inc. | Health Information Services | NASDAQ | 11.2B native | 42.2% | POTENTIALLY NON-COMPLIANT* |
| ELAN | Elanco Animal Health Inc | Drug Manufacturers - Specialty & Generic | NYSE | 11.2B native | 30.1% | POTENTIALLY NON-COMPLIANT* |
| TWST | Twist Bioscience Corp | Biotechnology | NASDAQ | 10.9B native | 11.8% | POTENTIALLY NON-COMPLIANT* |
| AXSM | Axsome Therapeutics, Inc. | Biotechnology | NASDAQ | 10.9B native | 31.6% | POTENTIALLY NON-COMPLIANT* |
| ALGN-nasdaq-148 | ALIGN TECHNOLOGY INC | Medical Instruments & Supplies | NASDAQ | 10.7B native | 1.8% | POTENTIALLY NON-COMPLIANT* |
| TXG | 10x Genomics, Inc. | Medical Devices | NASDAQ | 10.5B native | 8.1% | POTENTIALLY NON-COMPLIANT* |
| COO-nasdaq-1035 | COOPER COMPANIES, INC. | Medical Instruments & Supplies | NASDAQ | 10.5B native | 20.2% | MORE DATA NEEDED* |
| AVTR | Avantor, Inc. | Medical Instruments & Supplies | NYSE | 10.5B native | 33.5% | POTENTIALLY NON-COMPLIANT* |
| MOH | MOLINA HEALTHCARE, INC. | Healthcare Plans | NYSE | 10.5B native | 25.4% | POTENTIALLY NON-COMPLIANT* |
| UHS | UNIVERSAL HEALTH SERVICES INC | Medical Care Facilities | NYSE | 10.4B native | 33.3% | POTENTIALLY NON-COMPLIANT* |
| APGE | Apogee Therapeutics, Inc. | Biotechnology | NASDAQ | 10.2B native | 0.9% | POTENTIALLY NON-COMPLIANT* |
| RDY | DR REDDYS LABORATORIES LTD | Drug Manufacturers - Specialty & Generic | NYSE | 10.2B native | 13.3% | MORE DATA NEEDED* |
| ENSG | ENSIGN GROUP, INC | Medical Care Facilities | NASDAQ | 10.1B native | 40.4% | POTENTIALLY NON-COMPLIANT* |
| BIO | BIO-RAD LABORATORIES, INC. | Medical Devices | NYSE | 10.1B native | 13.1% | MORE DATA NEEDED* |
| RGEN | REPLIGEN CORP | Medical Instruments & Supplies | NASDAQ | 10.0B native | 23.4% | MORE DATA NEEDED* |
| FME | Fresenius Medical | Medical Care Facilities | XETRA | 10.0B native | 34.8% | POTENTIALLY NON-COMPLIANT* |
| KRYS | Krystal Biotech, Inc. | Biotechnology | NASDAQ | 10.0B native | 0.7% | POTENTIALLY NON-COMPLIANT* |
| GMED | GLOBUS MEDICAL INC | Medical Devices | NYSE | 9.9B native | 2.2% | MORE DATA NEEDED* |
| PODD-nasdaq-1017 | INSULET CORP | Medical Devices | NASDAQ | 9.8B native | 29.8% | POTENTIALLY NON-COMPLIANT* |
| KYMR | Kymera Therapeutics, Inc. | Biotechnology | NASDAQ | 9.7B native | 4.7% | POTENTIALLY NON-COMPLIANT* |
| GKOS | GLAUKOS Corp | Medical Devices | NYSE | 9.7B native | 11.6% | POTENTIALLY NON-COMPLIANT* |
| OSCR | Oscar Health, Inc. | Healthcare Plans | NYSE | 9.7B native | 6.8% | POTENTIALLY NON-COMPLIANT* |
| CYTK | CYTOKINETICS INC | Biotechnology | NASDAQ | 9.6B native | 90.2% | POTENTIALLY NON-COMPLIANT* |
| MASI | MASIMO CORP | Medical Devices | NASDAQ | 9.5B native | 32.9% | POTENTIALLY NON-COMPLIANT* |
| HSIC | HENRY SCHEIN INC | Medical Distribution | NASDAQ | 9.5B native | 30.6% | POTENTIALLY NON-COMPLIANT* |
| 4004 | Dallah Healthcare | Medical Care Facilities | SAU | 9.4B native | 43.1% | POTENTIALLY NON-COMPLIANT* |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Biotechnology | NASDAQ | 9.4B native | 26.4% | POTENTIALLY NON-COMPLIANT* |
| BRKR | BRUKER CORP | Medical Devices | NASDAQ | 9.4B native | 32.7% | POTENTIALLY NON-COMPLIANT* |
| PTGX | Protagonist Therapeutics, Inc | Biotechnology | NASDAQ | 9.3B native | 1.5% | POTENTIALLY NON-COMPLIANT* |
| SHL-asx-9132 | Sonic Healthcare | Diagnostics & Research | ASX | 9.2B native | 32.2% | POTENTIALLY NON-COMPLIANT* |
| ABVX | Abivax S.A. | Biotechnology | NASDAQ | 9.2B native | 0.3% | POTENTIALLY NON-COMPLIANT* |
| CRNX | Crinetics Pharmaceuticals, Inc. | Biotechnology | NASDAQ | 9.0B native | 4.3% | POTENTIALLY NON-COMPLIANT* |
| IBRX | ImmunityBio, Inc. | Biotechnology | NASDAQ | 9.0B native | 103.2% | POTENTIALLY NON-COMPLIANT* |
| QGEN | QIAGEN N.V. | Diagnostics & Research | NYSE | 8.9B native | 28.9% | MORE DATA NEEDED* |
| TGTX | TG THERAPEUTICS, INC. | Biotechnology | NASDAQ | 8.8B native | 23.9% | POTENTIALLY NON-COMPLIANT* |
| PCVX | Vaxcyte, Inc. | Biotechnology | NASDAQ | 8.7B native | 3.9% | POTENTIALLY NON-COMPLIANT* |
| HSIC-nyse-8280 | Henry Schein | Medical Distribution | NYSE | 8.5B native | 30.6% | POTENTIALLY NON-COMPLIANT* |
| CAI | Caris Life Sciences, Inc. | Biotechnology | NASDAQ | 8.5B native | 38.0% | POTENTIALLY NON-COMPLIANT* |
| PRAX | Praxis Precision Medicines, Inc. | Biotechnology | NASDAQ | 8.3B native | 0.0% | POTENTIALLY NON-COMPLIANT* |
| QIA | Qiagen | Diagnostics & Research | XETRA | 8.3B native | 28.9% | MORE DATA NEEDED* |
| SYRE | Spyre Therapeutics, Inc. | Biotechnology | NASDAQ | 8.1B native | N/A | MORE DATA NEEDED* |
| TECH-nyse-8230 | Bio-Techne | Biotechnology | NYSE | 8.0B native | 17.4% | MORE DATA NEEDED* |
| ATR | APTARGROUP, INC. | Medical Instruments & Supplies | NYSE | 7.9B native | 29.1% | MORE DATA NEEDED* |
| HQY | HEALTHEQUITY, INC. | Health Information Services | NASDAQ | 7.9B native | 29.6% | MORE DATA NEEDED* |
| IMVT | Immunovant, Inc. | Biotechnology | NASDAQ | 7.6B native | 0.0% | POTENTIALLY NON-COMPLIANT* |
| NUVL | Nuvalent, Inc. | Biotechnology | NASDAQ | 7.6B native | N/A | MORE DATA NEEDED* |
| HNGE | Hinge Health, Inc. | Health Information Services | NYSE | 7.6B native | 1.1% | POTENTIALLY NON-COMPLIANT* |
| IONS | IONIS PHARMACEUTICALS INC | Biotechnology | NASDAQ | 7.4B native | 58.6% | POTENTIALLY NON-COMPLIANT* |
| ALKS | Alkermes plc. | Drug Manufacturers - Specialty & Generic | NASDAQ | 7.3B native | 2.8% | MORE DATA NEEDED* |
| BIO-B | BIO-RAD LABORATORIES, INC. | Medical Devices | NYSE | 7.2B native | 13.1% | MORE DATA NEEDED* |
| AMRX | Amneal Pharmaceuticals, Inc. | Drug Manufacturers - Specialty & Generic | NASDAQ | 7.0B native | 73.1% | POTENTIALLY NON-COMPLIANT* |
| CGON | CG Oncology, Inc. | Biotechnology | NASDAQ | 6.9B native | 0.9% | POTENTIALLY NON-COMPLIANT* |
| BLTE | BELITE BIO, INC | Biotechnology | NASDAQ | 6.9B native | 0.1% | POTENTIALLY NON-COMPLIANT* |
| HIMS | Hims & Hers Health, Inc. | Drug Manufacturers - Specialty & Generic | NYSE | 6.8B native | 52.0% | POTENTIALLY NON-COMPLIANT* |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Biotechnology | NASDAQ | 6.7B native | 0.8% | POTENTIALLY NON-COMPLIANT* |
| ACLX | Arcellx, Inc. | Biotechnology | NASDAQ | 6.7B native | 8.6% | POTENTIALLY NON-COMPLIANT* |
| PACS | PACS Group, Inc. | Medical Care Facilities | NYSE | 6.7B native | 62.2% | POTENTIALLY NON-COMPLIANT* |
| CHE | CHEMED CORP | Medical Care Facilities | NYSE | 6.6B native | 9.3% | MORE DATA NEEDED* |
| LNTH | Lantheus Holdings, Inc. | Drug Manufacturers - Specialty & Generic | NASDAQ | 6.6B native | 27.8% | POTENTIALLY NON-COMPLIANT* |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | NASDAQ | 6.4B native | 5.4% | POTENTIALLY NON-COMPLIANT* |
| LQDA | Liquidia Corp | Drug Manufacturers - Specialty & Generic | NASDAQ | 6.1B native | 60.4% | POTENTIALLY NON-COMPLIANT* |
| KNSA | Kiniksa Pharmaceuticals International, plc | Drug Manufacturers - Specialty & Generic | NASDAQ | 6.1B native | 1.2% | POTENTIALLY NON-COMPLIANT* |
| BLCO | Bausch & Lomb Corp | Medical Instruments & Supplies | NYSE | 6.0B native | 36.2% | POTENTIALLY NON-COMPLIANT* |
| RDNT | RadNet, Inc. | Diagnostics & Research | NASDAQ | 6.0B native | 49.5% | POTENTIALLY NON-COMPLIANT* |
| TERN | Terns Pharmaceuticals, Inc. | Biotechnology | NASDAQ | 6.0B native | 0.4% | POTENTIALLY NON-COMPLIANT* |
| MIRM | Mirum Pharmaceuticals, Inc. | Biotechnology | NASDAQ | 6.0B native | 37.9% | POTENTIALLY NON-COMPLIANT* |
| KOD | Kodiak Sciences Inc. | Biotechnology | NASDAQ | 5.9B native | 16.8% | POTENTIALLY NON-COMPLIANT* |
| STVN | Stevanato Group S.p.A. | Medical Instruments & Supplies | NYSE | 5.9B native | 18.4% | MORE DATA NEEDED* |
| SRRK | Scholar Rock Holding Corp | Biotechnology | NASDAQ | 5.9B native | 26.9% | POTENTIALLY NON-COMPLIANT* |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Biotechnology | NASDAQ | 5.9B native | 0.3% | POTENTIALLY NON-COMPLIANT* |
| LGND | LIGAND PHARMACEUTICALS INC | Biotechnology | NASDAQ | 5.8B native | 28.9% | POTENTIALLY NON-COMPLIANT* |
| TVTX | Travere Therapeutics, Inc. | Biotechnology | NASDAQ | 5.7B native | 54.3% | POTENTIALLY NON-COMPLIANT* |
| BLLN | BillionToOne, Inc. | Diagnostics & Research | NASDAQ | 5.5B native | 17.2% | POTENTIALLY NON-COMPLIANT* |
| MANE | Veradermics, Inc | Biotechnology | NYSE | 5.5B native | 0.0% | POTENTIALLY NON-COMPLIANT* |
| CRSP | CRISPR Therapeutics AG | Biotechnology | NASDAQ | 5.5B native | 9.1% | POTENTIALLY NON-COMPLIANT* |
| COGT | Cogent Biosciences, Inc. | Biotechnology | NASDAQ | 5.5B native | 25.5% | POTENTIALLY NON-COMPLIANT* |
| PTCT | PTC THERAPEUTICS, INC. | Biotechnology | NASDAQ | 5.5B native | 93.4% | POTENTIALLY NON-COMPLIANT* |
| ORKA | Oruka Therapeutics, Inc. | Biotechnology | NASDAQ | 5.4B native | 0.4% | POTENTIALLY NON-COMPLIANT* |
| SHC | Sotera Health Co | Diagnostics & Research | NASDAQ | 5.3B native | 69.7% | POTENTIALLY NON-COMPLIANT* |
| TFX | TELEFLEX INC | Medical Instruments & Supplies | NYSE | 5.3B native | 39.2% | POTENTIALLY NON-COMPLIANT* |
| ERAS | Erasca, Inc. | Biotechnology | NASDAQ | 5.3B native | 11.9% | POTENTIALLY NON-COMPLIANT* |
| MMSI | MERIT MEDICAL SYSTEMS INC | Medical Instruments & Supplies | NASDAQ | 5.1B native | 30.6% | POTENTIALLY NON-COMPLIANT* |
| DFTX | Definium Therapeutics, Inc. | Biotechnology | NASDAQ | 5.0B native | 9.2% | POTENTIALLY NON-COMPLIANT* |
| GRFS | Grifols SA | Drug Manufacturers - General | NASDAQ | 5.0B native | 48.5% | POTENTIALLY NON-COMPLIANT* |
| HAE | HAEMONETICS CORP | Medical Devices | NYSE | 4.9B native | 51.1% | POTENTIALLY NON-COMPLIANT* |
| WAY | Waystar Holding Corp. | Health Information Services | NASDAQ | 4.9B native | 25.8% | MORE DATA NEEDED* |
| 4005 | National Medical Care | Medical Care Facilities | SAU | 4.9B native | 18.6% | POTENTIALLY NON-COMPLIANT* |
| EWTX | Edgewise Therapeutics, Inc. | Biotechnology | NASDAQ | 4.8B native | 0.7% | POTENTIALLY NON-COMPLIANT* |
| DOCS | Doximity, Inc. | Health Information Services | NYSE | 4.8B native | 0.9% | POTENTIALLY NON-COMPLIANT* |
| LFST | LifeStance Health Group, Inc. | Medical Care Facilities | NASDAQ | 4.8B native | 21.5% | MORE DATA NEEDED* |
| ACAD | ACADIA PHARMACEUTICALS INC | Biotechnology | NASDAQ | 4.5B native | 3.3% | POTENTIALLY NON-COMPLIANT* |
| FOLD | AMICUS THERAPEUTICS, INC. | Biotechnology | NASDAQ | 4.5B native | 46.6% | POTENTIALLY NON-COMPLIANT* |
| ADPT | Adaptive Biotechnologies Corp | Diagnostics & Research | NASDAQ | 4.5B native | 15.4% | POTENTIALLY NON-COMPLIANT* |
| CON-nyse-2094 | Concentra Group Holdings Parent, Inc. | Medical Care Facilities | NYSE | 4.4B native | 73.6% | POTENTIALLY NON-COMPLIANT* |
| VKTX | Viking Therapeutics, Inc. | Biotechnology | NASDAQ | 4.4B native | 0.0% | POTENTIALLY NON-COMPLIANT* |
| TLX | Telix Pharmaceuticals Ltd | Biotechnology | NASDAQ | 4.4B native | 40.1% | POTENTIALLY NON-COMPLIANT* |
| ITGR | Integer Holdings Corp | Medical Devices | NYSE | 4.3B native | 38.5% | POTENTIALLY NON-COMPLIANT* |
| LIVN | LivaNova PLC | Medical Devices | NASDAQ | 4.3B native | 16.6% | POTENTIALLY NON-COMPLIANT* |
| ABCL | AbCellera Biologics Inc. | Biotechnology | NASDAQ | 4.3B native | 10.6% | POTENTIALLY NON-COMPLIANT* |
| CNTA | Centessa Pharmaceuticals plc | Biotechnology | NASDAQ | 4.2B native | 20.3% | POTENTIALLY NON-COMPLIANT* |
| HTFL | Heartflow, Inc. | Health Information Services | NASDAQ | 4.2B native | 6.1% | POTENTIALLY NON-COMPLIANT* |
| INDV | Indivior Pharmaceuticals, Inc. | Drug Manufacturers - Specialty & Generic | NASDAQ | 4.2B native | 29.2% | POTENTIALLY NON-COMPLIANT* |
| RLAY | Relay Therapeutics, Inc. | Biotechnology | NASDAQ | 4.2B native | 5.2% | POTENTIALLY NON-COMPLIANT* |
| CELC | Celcuity Inc. | Biotechnology | NASDAQ | 4.1B native | 69.0% | POTENTIALLY NON-COMPLIANT* |
| MMED | MiniMed Group, Inc. | Health Information Services | NYSE | 4.1B native | 0.3% | MORE DATA NEEDED* |
| MMED-nasdaq-8380 | MMED | Health Information Services | NASDAQ | 4.1B native | 0.3% | MORE DATA NEEDED* |
| TNGX | Tango Therapeutics, Inc. | Biotechnology | NASDAQ | 3.9B native | 8.4% | POTENTIALLY NON-COMPLIANT* |
| ELVN | Enliven Therapeutics, Inc. | Biotechnology | NASDAQ | 3.9B native | 0.1% | POTENTIALLY NON-COMPLIANT* |
| ICUI | ICU MEDICAL INC/DE | Medical Instruments & Supplies | NASDAQ | 3.9B native | 32.9% | POTENTIALLY NON-COMPLIANT* |
| CPRX | CATALYST PHARMACEUTICALS, INC. | Biotechnology | NASDAQ | 3.9B native | 0.3% | POTENTIALLY NON-COMPLIANT* |
| IDYA | IDEAYA Biosciences, Inc. | Biotechnology | NASDAQ | 3.8B native | 2.5% | POTENTIALLY NON-COMPLIANT* |
| XENE | Xenon Pharmaceuticals Inc. | Biotechnology | NASDAQ | 3.8B native | 1.3% | POTENTIALLY NON-COMPLIANT* |
| NVST | Envista Holdings Corp | Medical Instruments & Supplies | NYSE | 3.8B native | 28.1% | MORE DATA NEEDED* |
| OPCH | Option Care Health, Inc. | Medical Care Facilities | NASDAQ | 3.6B native | 36.8% | POTENTIALLY NON-COMPLIANT* |
| IRTC | iRhythm Holdings, Inc. | Medical Devices | NASDAQ | 3.6B native | 71.7% | POTENTIALLY NON-COMPLIANT* |
| 2070 | Saudi Chemical | Drug Manufacturers - Specialty & Generic | SAU | 3.6B native | 32.8% | POTENTIALLY NON-COMPLIANT* |
| 4007 | Al Hammadi | Medical Care Facilities | SAU | 3.6B native | 10.5% | MORE DATA NEEDED* |
| CDNA | CareDx, Inc. | Diagnostics & Research | NASDAQ | 3.6B native | 6.3% | POTENTIALLY NON-COMPLIANT* |
| TARS | Tarsus Pharmaceuticals, Inc. | Biotechnology | NASDAQ | 3.6B native | 12.9% | POTENTIALLY NON-COMPLIANT* |
| LEGN | Legend Biotech Corp | Biotechnology | NASDAQ | 3.6B native | 23.9% | POTENTIALLY NON-COMPLIANT* |
| PLSE | PULSE BIOSCIENCES, INC. | Medical Instruments & Supplies | NASDAQ | 3.6B native | 8.0% | POTENTIALLY NON-COMPLIANT* |
| OGN | Organon & Co. | Drug Manufacturers - General | NYSE | 3.6B native | 67.2% | POTENTIALLY NON-COMPLIANT* |
| NHC-amex-8602 | NHC | Medical Care Facilities | AMEX | 3.6B native | 5.7% | MORE DATA NEEDED* |
| ARQT | Arcutis Biotherapeutics, Inc. | Biotechnology | NASDAQ | 3.5B native | 26.4% | POTENTIALLY NON-COMPLIANT* |
| NHC | NATIONAL HEALTHCARE CORP | Medical Care Facilities | NYSE | 3.5B native | 5.7% | MORE DATA NEEDED* |
| AMLX | Amylyx Pharmaceuticals, Inc. | Drug Manufacturers - Specialty & Generic | NASDAQ | 3.5B native | 1.8% | POTENTIALLY NON-COMPLIANT* |
| VCYT | VERACYTE, INC. | Diagnostics & Research | NASDAQ | 3.5B native | 2.8% | MORE DATA NEEDED* |
| GRAL | GRAIL, Inc. | Diagnostics & Research | NASDAQ | 3.4B native | 1.9% | POTENTIALLY NON-COMPLIANT* |
| RCUS | Arcus Biosciences, Inc. | Biotechnology | NYSE | 3.4B native | 9.8% | POTENTIALLY NON-COMPLIANT* |
| DNLI | Denali Therapeutics Inc. | Biotechnology | NASDAQ | 3.3B native | 3.2% | POTENTIALLY NON-COMPLIANT* |
| BHC | Bausch Health | Drug Manufacturers - Specialty & Generic | TSX | 3.2B native | 79.1% | POTENTIALLY NON-COMPLIANT* |
| DYN | Dyne Therapeutics, Inc. | Biotechnology | NASDAQ | 3.2B native | 14.3% | POTENTIALLY NON-COMPLIANT* |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Biotechnology | NASDAQ | 3.2B native | 47.3% | POTENTIALLY NON-COMPLIANT* |
| NEOG | NEOGEN CORP | Medical Devices | NASDAQ | 3.0B native | 23.7% | MORE DATA NEEDED* |
| GRDN | Guardian Pharmacy Services, Inc. | Medical Care Facilities | NYSE | 3.0B native | 9.0% | POTENTIALLY NON-COMPLIANT* |
| TMDX | TransMedics Group, Inc. | Medical Devices | NASDAQ | 3.0B native | 48.6% | POTENTIALLY NON-COMPLIANT* |
| CLDX | Celldex Therapeutics, Inc. | Biotechnology | NASDAQ | 3.0B native | 0.4% | POTENTIALLY NON-COMPLIANT* |
| IMNM | Immunome Inc. | Biotechnology | NASDAQ | 2.9B native | 0.6% | POTENTIALLY NON-COMPLIANT* |
| WRBY | Warby Parker Inc. | Medical Instruments & Supplies | NYSE | 2.8B native | 32.3% | POTENTIALLY NON-COMPLIANT* |
| WGS | GeneDx Holdings Corp. | Diagnostics & Research | NASDAQ | 2.8B native | 21.6% | POTENTIALLY NON-COMPLIANT* |
| MBX | MBX Biosciences, Inc. | Biotechnology | NASDAQ | 2.8B native | 0.2% | POTENTIALLY NON-COMPLIANT* |
| ATRC | AtriCure, Inc. | Medical Instruments & Supplies | NASDAQ | 2.8B native | 11.2% | POTENTIALLY NON-COMPLIANT* |
| ZLAB | Zai Lab Ltd | Biotechnology | NASDAQ | 2.8B native | 19.1% | POTENTIALLY NON-COMPLIANT* |
| PGEN | PRECIGEN, INC. | Biotechnology | NASDAQ | 2.8B native | 63.2% | POTENTIALLY NON-COMPLIANT* |
| AVAH | Aveanna Healthcare Holdings, Inc. | Medical Care Facilities | NASDAQ | 2.7B native | 75.3% | POTENTIALLY NON-COMPLIANT* |
| ATAI | Atai Beckley N.V. | Biotechnology | NASDAQ | 2.7B native | 0.7% | POTENTIALLY NON-COMPLIANT* |
| BKD | Brookdale Senior Living Inc. | Medical Care Facilities | NYSE | 2.7B native | 92.7% | POTENTIALLY NON-COMPLIANT* |
| BEAM | Beam Therapeutics Inc. | Biotechnology | NASDAQ | 2.7B native | 10.4% | POTENTIALLY NON-COMPLIANT* |
| PHVS | Pharvaris N.V. | Biotechnology | NASDAQ | 2.7B native | 0.3% | POTENTIALLY NON-COMPLIANT* |
| NAMS | NewAmsterdam Pharma Co N.V. | Biotechnology | NASDAQ | 2.6B native | 0.0% | POTENTIALLY NON-COMPLIANT* |
| IRON | Disc Medicine, Inc. | Biotechnology | NASDAQ | 2.6B native | 3.8% | POTENTIALLY NON-COMPLIANT* |
| GPCR | Structure Therapeutics Inc. | Biotechnology | NASDAQ | 2.6B native | 0.4% | POTENTIALLY NON-COMPLIANT* |
| VERA | Vera Therapeutics, Inc. | Biotechnology | NASDAQ | 2.6B native | 10.5% | POTENTIALLY NON-COMPLIANT* |
| MLYS | Mineralys Therapeutics, Inc. | Biotechnology | NASDAQ | 2.6B native | N/A | MORE DATA NEEDED* |
| ACHC | Acadia Healthcare Company, Inc. | Medical Care Facilities | NASDAQ | 2.5B native | 47.8% | POTENTIALLY NON-COMPLIANT* |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Drug Manufacturers - Specialty & Generic | NASDAQ | 2.5B native | 2.8% | MORE DATA NEEDED* |
| 4009 | Saudi Tadawul Group | Medical Care Facilities | SAU | 2.5B native | 46.5% | POTENTIALLY NON-COMPLIANT* |
| VRDN | Viridian Therapeutics, Inc.\DE | Biotechnology | NASDAQ | 2.5B native | 5.6% | POTENTIALLY NON-COMPLIANT* |
| CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | Healthcare Plans | NASDAQ | 2.5B native | N/A | POTENTIALLY NON-COMPLIANT* |
| PRVA | Privia Health Group, Inc. | Health Information Services | NASDAQ | 2.5B native | 0.7% | POTENTIALLY NON-COMPLIANT* |
| NEO | NEOGENOMICS INC | Diagnostics & Research | NASDAQ | 2.5B native | 30.1% | POTENTIALLY NON-COMPLIANT* |
| HCM | HUTCHMED (China) Ltd | Drug Manufacturers - Specialty & Generic | NASDAQ | 2.4B native | 5.6% | POTENTIALLY NON-COMPLIANT* |
| NRIX | Nurix Therapeutics, Inc. | Biotechnology | NASDAQ | 2.4B native | 8.1% | POTENTIALLY NON-COMPLIANT* |
| HRMY | Harmony Biosciences Holdings, Inc. | Biotechnology | NASDAQ | 2.3B native | 12.9% | POTENTIALLY NON-COMPLIANT* |
| SLS | SELLAS Life Sciences Group, Inc. | Biotechnology | NASDAQ | 2.3B native | 1.3% | POTENTIALLY NON-COMPLIANT* |
| NKTR | NEKTAR THERAPEUTICS | Biotechnology | NASDAQ | 2.3B native | 30.6% | POTENTIALLY NON-COMPLIANT* |
| PBH | Prestige Consumer Healthcare Inc. | Drug Manufacturers - Specialty & Generic | NYSE | 2.3B native | 29.9% | MORE DATA NEEDED* |
| OCUL | OCULAR THERAPEUTIX, INC | Biotechnology | NASDAQ | 2.2B native | 9.5% | POTENTIALLY NON-COMPLIANT* |
| DAWN | Day One Biopharmaceuticals, Inc. | Biotechnology | NASDAQ | 2.2B native | 0.6% | POTENTIALLY NON-COMPLIANT* |
| BFLY | Butterfly Network, Inc. | Medical Devices | NYSE | 2.2B native | 6.9% | POTENTIALLY NON-COMPLIANT* |
| AXGN | Axogen, Inc. | Medical Devices | NASDAQ | 2.2B native | 30.5% | POTENTIALLY NON-COMPLIANT* |
| SRPT | Sarepta Therapeutics, Inc. | Biotechnology | NASDAQ | 2.2B native | 31.0% | POTENTIALLY NON-COMPLIANT* |
| ALVO | Alvotech | Drug Manufacturers - Specialty & Generic | NASDAQ | 2.2B native | 97.4% | POTENTIALLY NON-COMPLIANT* |
| APLS | Apellis Pharmaceuticals, Inc. | Biotechnology | NASDAQ | 2.2B native | 44.1% | POTENTIALLY NON-COMPLIANT* |
| MD | Pediatrix Medical Group, Inc. | Medical Care Facilities | NYSE | 2.2B native | 28.2% | MORE DATA NEEDED* |
| ADUS | Addus HomeCare Corp | Medical Care Facilities | NASDAQ | 2.2B native | 11.9% | MORE DATA NEEDED* |
| SDGR | Schrodinger, Inc. | Health Information Services | NASDAQ | 2.2B native | 15.0% | POTENTIALLY NON-COMPLIANT* |
| AUPH | Aurinia Pharmaceuticals Inc. | Biotechnology | NASDAQ | 2.1B native | 10.0% | POTENTIALLY NON-COMPLIANT* |
| UFPT | UFP TECHNOLOGIES INC | Medical Devices | NASDAQ | 2.1B native | 23.6% | MORE DATA NEEDED* |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | Medical Devices | NASDAQ | 2.1B native | 74.0% | POTENTIALLY NON-COMPLIANT* |
| PGNY | Progyny, Inc. | Healthcare Plans | NASDAQ | 2.1B native | 3.7% | POTENTIALLY NON-COMPLIANT* |
| ADMA | ADMA BIOLOGICS, INC. | Biotechnology | NASDAQ | 2.1B native | 12.8% | POTENTIALLY NON-COMPLIANT* |
| BHC-nyse-2276 | Bausch Health Companies Inc. | Drug Manufacturers - Specialty & Generic | NYSE | 2.1B native | 79.1% | POTENTIALLY NON-COMPLIANT* |
| URGN | UroGen Pharma Ltd. | Biotechnology | NASDAQ | 2.1B native | 64.0% | POTENTIALLY NON-COMPLIANT* |
| BCRX | BIOCRYST PHARMACEUTICALS INC | Drug Manufacturers - Specialty & Generic | NASDAQ | 2.1B native | 85.4% | POTENTIALLY NON-COMPLIANT* |
| NUVB | Nuvation Bio Inc. | Biotechnology | NYSE | 2.0B native | 9.6% | POTENTIALLY NON-COMPLIANT* |
| VCEL | Vericel Corp | Biotechnology | NASDAQ | 2.0B native | 19.7% | POTENTIALLY NON-COMPLIANT* |
| SEM | SELECT MEDICAL HOLDINGS CORP | Medical Care Facilities | NYSE | 2.0B native | 49.0% | POTENTIALLY NON-COMPLIANT* |
| XRAY | DENTSPLY SIRONA Inc. | Medical Instruments & Supplies | NASDAQ | 2.0B native | 45.5% | POTENTIALLY NON-COMPLIANT* |
| TRVI | Trevi Therapeutics, Inc. | Biotechnology | NASDAQ | 2.0B native | 0.4% | POTENTIALLY NON-COMPLIANT* |
| FTRE | Fortrea Holdings Inc. | Biotechnology | NASDAQ | 2.0B native | 41.1% | POTENTIALLY NON-COMPLIANT* |
| BHVN | Biohaven Ltd. | Biotechnology | NYSE | 2.0B native | 63.0% | POTENTIALLY NON-COMPLIANT* |
| AGIO | AGIOS PHARMACEUTICALS, INC. | Biotechnology | NASDAQ | 2.0B native | 3.1% | POTENTIALLY NON-COMPLIANT* |
| MESO | MESOBLAST LTD | Biotechnology | NASDAQ | 1.9B native | 16.5% | MORE DATA NEEDED* |
| GLPG | GALAPAGOS NV | Biotechnology | NASDAQ | 1.9B native | 0.3% | POTENTIALLY NON-COMPLIANT* |
| PVLA | PALVELLA THERAPEUTICS, INC. | Biotechnology | NASDAQ | 1.9B native | 1.1% | POTENTIALLY NON-COMPLIANT* |
| VIR | Vir Biotechnology, Inc. | Biotechnology | NASDAQ | 1.9B native | 9.8% | POTENTIALLY NON-COMPLIANT* |
| BLFS | BIOLIFE SOLUTIONS INC | Medical Instruments & Supplies | NASDAQ | 1.9B native | 4.4% | MORE DATA NEEDED* |
| PRGO | PERRIGO Co plc | Drug Manufacturers - Specialty & Generic | NYSE | 1.9B native | 42.6% | POTENTIALLY NON-COMPLIANT* |
| AZTA | Azenta, Inc. | Medical Instruments & Supplies | NASDAQ | 1.9B native | 2.5% | MORE DATA NEEDED* |
| ZYME | Zymeworks Inc. | Biotechnology | NASDAQ | 1.9B native | 5.3% | POTENTIALLY NON-COMPLIANT* |
| XERS | Xeris Biopharma Holdings, Inc. | Drug Manufacturers - Specialty & Generic | NASDAQ | 1.8B native | 67.3% | POTENTIALLY NON-COMPLIANT* |
| ZBIO | Zenas BioPharma, Inc. | Biotechnology | NASDAQ | 1.8B native | 0.3% | POTENTIALLY NON-COMPLIANT* |
| LMAT | LEMAITRE VASCULAR INC | Medical Instruments & Supplies | NASDAQ | 1.8B native | 30.1% | POTENTIALLY NON-COMPLIANT* |
| ASTH | Astrana Health, Inc. | Medical Care Facilities | NASDAQ | 1.8B native | 48.6% | POTENTIALLY NON-COMPLIANT* |
| INSP | Inspire Medical Systems, Inc. | Medical Devices | NYSE | 1.8B native | 3.5% | POTENTIALLY NON-COMPLIANT* |
| STOK | Stoke Therapeutics, Inc. | Biotechnology | NASDAQ | 1.8B native | 0.7% | POTENTIALLY NON-COMPLIANT* |
| XNCR | Xencor Inc | Biotechnology | NASDAQ | 1.8B native | 21.4% | POTENTIALLY NON-COMPLIANT* |
| SGRY | Surgery Partners, Inc. | Medical Care Facilities | NASDAQ | 1.8B native | 49.6% | POTENTIALLY NON-COMPLIANT* |
| SEPN | Septerna, Inc. | Biotechnology | NASDAQ | 1.8B native | 4.0% | POTENTIALLY NON-COMPLIANT* |
| TYRA | Tyra Biosciences, Inc. | Biotechnology | NASDAQ | 1.7B native | 2.1% | POTENTIALLY NON-COMPLIANT* |
| ABSI | Absci Corp | Biotechnology | NASDAQ | 1.7B native | 2.5% | POTENTIALLY NON-COMPLIANT* |
| NVCR | NovoCure Ltd | Medical Devices | NASDAQ | 1.7B native | 30.9% | POTENTIALLY NON-COMPLIANT* |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Biotechnology | NASDAQ | 1.7B native | 5.3% | POTENTIALLY NON-COMPLIANT* |
| GLTO | Galecto, Inc. | Biotechnology | NASDAQ | 1.7B native | 0.4% | POTENTIALLY NON-COMPLIANT* |
| ALHC | Alignment Healthcare, Inc. | Healthcare Plans | NASDAQ | 1.7B native | 30.9% | POTENTIALLY NON-COMPLIANT* |
| SNDA | SONIDA SENIOR LIVING, INC. | Medical Care Facilities | NYSE | 1.7B native | 81.6% | POTENTIALLY NON-COMPLIANT* |
| NVAX | NOVAVAX INC | Biotechnology | NASDAQ | 1.7B native | 21.1% | POTENTIALLY NON-COMPLIANT* |
| NTLA | Intellia Therapeutics, Inc. | Biotechnology | NASDAQ | 1.7B native | 11.1% | POTENTIALLY NON-COMPLIANT* |
| PSNL | Personalis, Inc. | Diagnostics & Research | NASDAQ | 1.7B native | 12.0% | POTENTIALLY NON-COMPLIANT* |
| RAPT | RAPT Therapeutics, Inc. | Biotechnology | NASDAQ | 1.7B native | 1.9% | POTENTIALLY NON-COMPLIANT* |
| ANIP | ANI PHARMACEUTICALS INC | Drug Manufacturers - Specialty & Generic | NASDAQ | 1.7B native | 42.8% | POTENTIALLY NON-COMPLIANT* |
| ATEC | Alphatec Holdings, Inc. | Medical Devices | NASDAQ | 1.6B native | 75.3% | POTENTIALLY NON-COMPLIANT* |
| FBRX | Forte Biosciences, Inc. | Biotechnology | NASDAQ | 1.6B native | N/A | POTENTIALLY NON-COMPLIANT* |
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | Medical Instruments & Supplies | NASDAQ | 1.6B native | 13.1% | POTENTIALLY NON-COMPLIANT* |
| QURE | uniQure N.V. | Biotechnology | NASDAQ | 1.6B native | 7.7% | POTENTIALLY NON-COMPLIANT* |
| SNDX | Syndax Pharmaceuticals Inc | Biotechnology | NASDAQ | 1.6B native | 65.2% | POTENTIALLY NON-COMPLIANT* |
| SLNO | SOLENO THERAPEUTICS INC | Biotechnology | NASDAQ | 1.6B native | 9.3% | POTENTIALLY NON-COMPLIANT* |
| ETON | Eton Pharmaceuticals, Inc. | Drug Manufacturers - Specialty & Generic | NASDAQ | 1.6B native | 33.7% | POTENTIALLY NON-COMPLIANT* |
| CMPS | COMPASS Pathways plc | Medical Care Facilities | NASDAQ | 1.6B native | 16.7% | POTENTIALLY NON-COMPLIANT* |
| RAPP | Rapport Therapeutics, Inc. | Biotechnology | NASDAQ | 1.5B native | 2.2% | POTENTIALLY NON-COMPLIANT* |
| CERT | Certara, Inc. | Health Information Services | NASDAQ | 1.5B native | 19.7% | MORE DATA NEEDED* |
| IMCR | Immunocore Holdings plc | Biotechnology | NASDAQ | 1.5B native | 40.9% | POTENTIALLY NON-COMPLIANT* |
| GHRS | GH Research PLC | Biotechnology | NASDAQ | 1.5B native | 0.2% | POTENTIALLY NON-COMPLIANT* |
| AGL-nyse-4343 | agilon health, inc. | Medical Care Facilities | NYSE | 1.5B native | 2.9% | POTENTIALLY NON-COMPLIANT* |
| ARDT | Ardent Health, Inc. | Medical Care Facilities | NYSE | 1.5B native | 43.8% | POTENTIALLY NON-COMPLIANT* |
| INVA | Innoviva, Inc. | Biotechnology | NASDAQ | 1.5B native | 16.5% | POTENTIALLY NON-COMPLIANT* |
| NUTX | Nutex Health, Inc. | Medical Care Facilities | NASDAQ | 1.5B native | 38.3% | POTENTIALLY NON-COMPLIANT* |
| OMCL | OMNICELL, INC. | Health Information Services | NASDAQ | 1.5B native | 10.3% | MORE DATA NEEDED* |
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | Biotechnology | NASDAQ | 1.5B native | 49.9% | POTENTIALLY NON-COMPLIANT* |
| TSHA | Taysha Gene Therapies, Inc. | Biotechnology | NASDAQ | 1.5B native | 20.4% | POTENTIALLY NON-COMPLIANT* |
| ANAB | ANAPTYSBIO, INC | Biotechnology | NASDAQ | 1.5B native | 3.9% | POTENTIALLY NON-COMPLIANT* |
| HCSG | HEALTHCARE SERVICES GROUP INC | Medical Care Facilities | NASDAQ | 1.4B native | 1.2% | POTENTIALLY NON-COMPLIANT* |
| PAHC | PHIBRO ANIMAL HEALTH CORP | Drug Manufacturers - Specialty & Generic | NASDAQ | 1.4B native | 52.5% | POTENTIALLY NON-COMPLIANT* |
| AMN | AMN HEALTHCARE SERVICES INC | Medical Care Facilities | NYSE | 1.4B native | 38.4% | POTENTIALLY NON-COMPLIANT* |
| PNTG | Pennant Group, Inc. | Medical Care Facilities | NASDAQ | 1.4B native | 46.8% | POTENTIALLY NON-COMPLIANT* |
| INBX | Inhibrx Biosciences, Inc. | Biotechnology | NASDAQ | 1.4B native | 73.1% | POTENTIALLY NON-COMPLIANT* |
| MAZE | Maze Therapeutics, Inc. | Biotechnology | NASDAQ | 1.3B native | 5.9% | POTENTIALLY NON-COMPLIANT* |
| OMER | OMEROS CORP | Biotechnology | NASDAQ | 1.3B native | 73.4% | POTENTIALLY NON-COMPLIANT* |
| DRTS | Alpha Tau Medical Ltd. | Biotechnology | NASDAQ | 1.3B native | 13.0% | POTENTIALLY NON-COMPLIANT* |
| CNMD | CONMED Corp | Medical Devices | NYSE | 1.3B native | 35.9% | POTENTIALLY NON-COMPLIANT* |
| ORIC | Oric Pharmaceuticals, Inc. | Biotechnology | NASDAQ | 1.3B native | 0.8% | POTENTIALLY NON-COMPLIANT* |
| RARE | Ultragenyx Pharmaceutical Inc. | Biotechnology | NASDAQ | 1.3B native | 2.3% | POTENTIALLY NON-COMPLIANT* |
| NBTX | Nanobiotix S.A. | Biotechnology | NASDAQ | 1.3B native | 140.7% | POTENTIALLY NON-COMPLIANT* |
| OMDA | Omada Health, Inc. | Health Information Services | NASDAQ | 1.3B native | 0.0% | POTENTIALLY NON-COMPLIANT* |
| HROW | HARROW, INC. | Drug Manufacturers - Specialty & Generic | NASDAQ | 1.3B native | 63.1% | POTENTIALLY NON-COMPLIANT* |
| USPH | U S PHYSICAL THERAPY INC /NV | Medical Care Facilities | NYSE | 1.2B native | 26.2% | MORE DATA NEEDED* |
| REPL | Replimune Group, Inc. | Biotechnology | NASDAQ | 1.2B native | 33.6% | POTENTIALLY NON-COMPLIANT* |
| MNKD | MANNKIND CORP | Biotechnology | NASDAQ | 1.2B native | 46.4% | POTENTIALLY NON-COMPLIANT* |
| INNV | InnovAge Holding Corp. | Medical Care Facilities | NASDAQ | 1.2B native | 15.6% | MORE DATA NEEDED* |
| CRON | Cronos Group Inc. | Drug Manufacturers - Specialty & Generic | NASDAQ | 1.2B native | 0.1% | POTENTIALLY NON-COMPLIANT* |
| GDRX | GoodRx Holdings, Inc. | Health Information Services | NASDAQ | 1.2B native | 38.7% | POTENTIALLY NON-COMPLIANT* |
| IMTX | Immatics N.V. | Biotechnology | NASDAQ | 1.2B native | 2.8% | POTENTIALLY NON-COMPLIANT* |
| TNDM | TANDEM DIABETES CARE INC | Medical Devices | NASDAQ | 1.1B native | 50.4% | POTENTIALLY NON-COMPLIANT* |
| STAA | STAAR SURGICAL CO | Medical Instruments & Supplies | NASDAQ | 1.1B native | 8.5% | POTENTIALLY NON-COMPLIANT* |
| VOR | Vor Biopharma Inc. | Biotechnology | NASDAQ | 1.1B native | 0.6% | POTENTIALLY NON-COMPLIANT* |
| IRMD | IRADIMED CORP | Medical Devices | NASDAQ | 1.1B native | 0.0% | POTENTIALLY NON-COMPLIANT* |
| AORT | ARTIVION, INC. | Medical Devices | NYSE | 1.1B native | 29.1% | MORE DATA NEEDED* |
| LBRX | LB PHARMACEUTICALS INC | Biotechnology | NASDAQ | 1.1B native | 1.1% | POTENTIALLY NON-COMPLIANT* |
| BCAX | Bicara Therapeutics Inc. | Biotechnology | NASDAQ | 1.1B native | 0.4% | POTENTIALLY NON-COMPLIANT* |
| OPK | OPKO HEALTH, INC. | Diagnostics & Research | NASDAQ | 1.1B native | 20.5% | MORE DATA NEEDED* |
| AMPH | Amphastar Pharmaceuticals, Inc. | Drug Manufacturers - Specialty & Generic | NASDAQ | 1.1B native | 40.3% | POTENTIALLY NON-COMPLIANT* |
| ENOV | Enovis CORP | Medical Devices | NYSE | 1.0B native | 36.0% | POTENTIALLY NON-COMPLIANT* |
| MGTX | MeiraGTx Holdings plc | Biotechnology | NASDAQ | 1.0B native | 36.3% | POTENTIALLY NON-COMPLIANT* |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | Medical Devices | NASDAQ | 1.0B native | 56.4% | POTENTIALLY NON-COMPLIANT* |
| AKTS | Aktis Oncology, Inc. | Biotechnology | NASDAQ | 1.0B native | 4.4% | POTENTIALLY NON-COMPLIANT* |
| JANX | Janux Therapeutics, Inc. | Biotechnology | NASDAQ | 1.0B native | 2.2% | POTENTIALLY NON-COMPLIANT* |
| ALMS | ALUMIS INC. | Biotechnology | NASDAQ | 1.0B native | 9.0% | POTENTIALLY NON-COMPLIANT* |
| CSTL | CASTLE BIOSCIENCES INC | Diagnostics & Research | NASDAQ | 1.0B native | 6.4% | POTENTIALLY NON-COMPLIANT* |
| TDOC | Teladoc Health, Inc. | Health Information Services | NYSE | 1.0B native | 36.4% | POTENTIALLY NON-COMPLIANT* |
| PIII | P3 Health Partners Inc. | Medical Care Facilities | NASDAQ | 1.0B native | 43.4% | POTENTIALLY NON-COMPLIANT* |
| ANL | Adlai Nortye Ltd. | Biotechnology | NASDAQ | 1.0B native | 76.6% | POTENTIALLY NON-COMPLIANT* |
| VTYX | Ventyx Biosciences, Inc. | Biotechnology | NASDAQ | 1.0B native | 3.9% | POTENTIALLY NON-COMPLIANT* |
| CGEM | Cullinan Therapeutics, Inc. | Biotechnology | NASDAQ | 999M native | 0.6% | POTENTIALLY NON-COMPLIANT* |
| PCRX | Pacira BioSciences, Inc. | Drug Manufacturers - Specialty & Generic | NASDAQ | 999M native | 33.1% | POTENTIALLY NON-COMPLIANT* |
| AHG | Akso Health Group | Medical Distribution | NASDAQ | 994M native | 0.2% | MORE DATA NEEDED* |
| LMRI | Lumexa Imaging Holdings, Inc. | Medical Devices | NASDAQ | 991M native | 54.5% | POTENTIALLY NON-COMPLIANT* |
| KALV | KalVista Pharmaceuticals, Inc. | Biotechnology | NASDAQ | 990M native | 2.5% | POTENTIALLY NON-COMPLIANT* |
| HSTM | HEALTHSTREAM INC | Health Information Services | NASDAQ | 982M native | 2.8% | MORE DATA NEEDED* |
| SVRA | Savara Inc | Biotechnology | NASDAQ | 982M native | 11.8% | POTENTIALLY NON-COMPLIANT* |
| PRCT | PROCEPT BioRobotics Corp | Medical Devices | NASDAQ | 977M native | 15.4% | POTENTIALLY NON-COMPLIANT* |
| BBNX | Beta Bionics, Inc. | Medical Devices | NASDAQ | 975M native | 2.2% | POTENTIALLY NON-COMPLIANT* |
| MLTX | MoonLake Immunotherapeutics | Biotechnology | NASDAQ | 969M native | 17.8% | POTENTIALLY NON-COMPLIANT* |
| ANRO | Alto Neuroscience, Inc. | Biotechnology | NYSE | 956M native | 13.0% | POTENTIALLY NON-COMPLIANT* |
| SLBT | SL Science Holding Ltd | Biotechnology | NYSE | 942M native | 7.6% | POTENTIALLY NON-COMPLIANT* |
| KURA | Kura Oncology, Inc. | Biotechnology | NASDAQ | 937M native | 2.8% | POTENTIALLY NON-COMPLIANT* |
| CBLL | Ceribell, Inc. | Medical Devices | NASDAQ | 934M native | 11.4% | POTENTIALLY NON-COMPLIANT* |
| CRVS | Corvus Pharmaceuticals, Inc. | Biotechnology | NASDAQ | 917M native | 1.3% | POTENTIALLY NON-COMPLIANT* |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Biotechnology | NASDAQ | 899M native | 34.0% | POTENTIALLY NON-COMPLIANT* |
| RIGL | RIGEL PHARMACEUTICALS INC | Biotechnology | NASDAQ | 896M native | 10.4% | POTENTIALLY NON-COMPLIANT* |
| GLUE | Monte Rosa Therapeutics, Inc. | Biotechnology | NASDAQ | 896M native | 8.7% | POTENTIALLY NON-COMPLIANT* |
| TBPH | Theravance Biopharma, Inc. | Biotechnology | NASDAQ | 884M native | 8.8% | POTENTIALLY NON-COMPLIANT* |
| DNA | Ginkgo Bioworks Holdings, Inc. | Biotechnology | NYSE | 875M native | 39.3% | POTENTIALLY NON-COMPLIANT* |
| BVS | Bioventus Inc. | Medical Devices | NASDAQ | 872M native | 43.0% | POTENTIALLY NON-COMPLIANT* |
| TALK | Talkspace, Inc. | Health Information Services | NASDAQ | 871M native | N/A | POTENTIALLY NON-COMPLIANT* |
| ARDX | ARDELYX, INC. | Biotechnology | NASDAQ | 862M native | 41.5% | POTENTIALLY NON-COMPLIANT* |
| SANA | Sana Biotechnology, Inc. | Biotechnology | NASDAQ | 862M native | 18.9% | POTENTIALLY NON-COMPLIANT* |
| HELP | CYBIN INC. | Biotechnology | NASDAQ | 862M native | N/A | POTENTIALLY NON-COMPLIANT* |
| WVE | Wave Life Sciences Ltd. | Biotechnology | NASDAQ | 857M native | 2.8% | POTENTIALLY NON-COMPLIANT* |
| SIBN | SI-BONE, Inc. | Medical Devices | NASDAQ | 856M native | 15.4% | POTENTIALLY NON-COMPLIANT* |
| SGP | SpyGlass Pharma, Inc. | Biotechnology | NASDAQ | 856M native | 1.4% | POTENTIALLY NON-COMPLIANT* |
| OLMA | Olema Pharmaceuticals, Inc. | Biotechnology | NASDAQ | 856M native | 0.8% | POTENTIALLY NON-COMPLIANT* |
| JBIO | Jade Biosciences, Inc. | Biotechnology | NASDAQ | 853M native | 0.2% | POTENTIALLY NON-COMPLIANT* |
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Medical Devices | NASDAQ | 845M native | 89.6% | POTENTIALLY NON-COMPLIANT* |
| IVA | Inventiva S.A. | Biotechnology | NASDAQ | 841M native | 24.0% | POTENTIALLY NON-COMPLIANT* |
| INMD | InMode Ltd. | Medical Devices | NASDAQ | 805M native | 1.1% | POTENTIALLY NON-COMPLIANT* |
| IMMX | Immix Biopharma, Inc. | Biotechnology | NASDAQ | 784M native | 1.0% | POTENTIALLY NON-COMPLIANT* |
| VREX | Varex Imaging Corp | Medical Devices | NASDAQ | 783M native | 35.8% | POTENTIALLY NON-COMPLIANT* |
| GERN | GERON CORP | Biotechnology | NASDAQ | 777M native | 21.4% | POTENTIALLY NON-COMPLIANT* |
| AHCO | AdaptHealth Corp. | Medical Devices | NASDAQ | 766M native | 44.1% | POTENTIALLY NON-COMPLIANT* |
| ANNX | Annexon, Inc. | Biotechnology | NASDAQ | 764M native | 9.4% | POTENTIALLY NON-COMPLIANT* |
| VSTM | Verastem, Inc. | Biotechnology | NASDAQ | 759M native | 35.4% | POTENTIALLY NON-COMPLIANT* |
| GYRE | GYRE THERAPEUTICS, INC. | Biotechnology | NASDAQ | 751M native | 0.6% | POTENTIALLY NON-COMPLIANT* |
| AVBP | ArriVent BioPharma, Inc. | Biotechnology | NASDAQ | 744M native | 0.0% | POTENTIALLY NON-COMPLIANT* |
| QDEL | QuidelOrtho Corp | Medical Devices | NASDAQ | 739M native | 49.1% | POTENTIALLY NON-COMPLIANT* |
| SLDB | Solid Biosciences Inc. | Biotechnology | NASDAQ | 734M native | 9.1% | POTENTIALLY NON-COMPLIANT* |
| DSGN | Design Therapeutics, Inc. | Biotechnology | NASDAQ | 732M native | 0.7% | POTENTIALLY NON-COMPLIANT* |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Biotechnology | NASDAQ | 722M native | 35.8% | POTENTIALLY NON-COMPLIANT* |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | Drug Manufacturers - Specialty & Generic | NASDAQ | 717M native | 49.2% | POTENTIALLY NON-COMPLIANT* |
| AVTX | Avalo Therapeutics, Inc. | Biotechnology | NASDAQ | 710M native | 0.3% | POTENTIALLY NON-COMPLIANT* |
| CADL | Candel Therapeutics, Inc. | Biotechnology | NASDAQ | 709M native | 39.2% | POTENTIALLY NON-COMPLIANT* |
| ESPR | Esperion Therapeutics, Inc. | Drug Manufacturers - Specialty & Generic | NASDAQ | 704M native | 54.1% | POTENTIALLY NON-COMPLIANT* |
| FDMT | 4D Molecular Therapeutics, Inc. | Biotechnology | NASDAQ | 696M native | 3.8% | POTENTIALLY NON-COMPLIANT* |
| CTKB | Cytek Biosciences, Inc. | Medical Devices | NASDAQ | 694M native | 5.1% | POTENTIALLY NON-COMPLIANT* |
| PHAR | Pharming Group N.V. | Biotechnology | NASDAQ | 694M native | 23.2% | POTENTIALLY NON-COMPLIANT* |
| EHAB | Enhabit, Inc. | Medical Care Facilities | NYSE | 693M native | 42.8% | POTENTIALLY NON-COMPLIANT* |
| ABUS | Arbutus Biopharma Corp | Biotechnology | NASDAQ | 687M native | 0.8% | POTENTIALLY NON-COMPLIANT* |
| AURA | Aura Biosciences, Inc. | Biotechnology | NASDAQ | 678M native | 10.3% | POTENTIALLY NON-COMPLIANT* |
| MDXG | MIMEDX GROUP, INC. | Biotechnology | NASDAQ | 674M native | 5.2% | POTENTIALLY NON-COMPLIANT* |
| AVR | Anteris Technologies Global Corp. | Medical Devices | NASDAQ | 665M native | 9.9% | POTENTIALLY NON-COMPLIANT* |
| ZVRA | ZEVRA THERAPEUTICS, INC. | Biotechnology | NASDAQ | 658M native | 22.2% | POTENTIALLY NON-COMPLIANT* |
| DBVT | DBV Technologies S.A. | Biotechnology | NASDAQ | 656M native | 3.4% | POTENTIALLY NON-COMPLIANT* |
| VALN | Valneva SE | Biotechnology | NASDAQ | 653M native | 52.0% | POTENTIALLY NON-COMPLIANT* |
| PHR | Phreesia, Inc. | Health Information Services | NYSE | 652M native | 15.4% | POTENTIALLY NON-COMPLIANT* |
| PRME | Prime Medicine, Inc. | Biotechnology | NASDAQ | 635M native | 34.0% | POTENTIALLY NON-COMPLIANT* |
| AVNS | AVANOS MEDICAL, INC. | Medical Devices | NYSE | 629M native | 12.0% | MORE DATA NEEDED* |
| PROK | PROKIDNEY CORP. | Biotechnology | NASDAQ | 627M native | 1.2% | POTENTIALLY NON-COMPLIANT* |
| CLYM | Climb Bio, Inc. | Biotechnology | NASDAQ | 624M native | 0.3% | POTENTIALLY NON-COMPLIANT* |
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.